Shogo Misumi

2.1k total citations
84 papers, 1.4k citations indexed

About

Shogo Misumi is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Shogo Misumi has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 38 papers in Virology and 31 papers in Infectious Diseases. Recurrent topics in Shogo Misumi's work include HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (26 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers). Shogo Misumi is often cited by papers focused on HIV Research and Treatment (38 papers), HIV/AIDS drug development and treatment (26 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers). Shogo Misumi collaborates with scholars based in Japan, United States and Egypt. Shogo Misumi's co-authors include Nobutoki Takamune, Shozo Shoji, Naoki Kishimoto, Taishi Higashi, Hidetoshi Arima, Kaneto Uekama, Fumitoshi Hirayama, Yukio Ando, Keiichi Motoyama and Masaaki Nakamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Shogo Misumi

82 papers receiving 1.3k citations

Peers

Countries citing papers authored by Shogo Misumi

Since Specialization

Citations

This map shows the geographic impact of Shogo Misumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shogo Misumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shogo Misumi more than expected).

Fields of papers citing papers by Shogo Misumi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shogo Misumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shogo Misumi. The network helps show where Shogo Misumi may publish in the future.

Co-authorship network of co-authors of Shogo Misumi

This figure shows the co-authorship network connecting the top 25 collaborators of Shogo Misumi. A scholar is included among the top collaborators of Shogo Misumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shogo Misumi. Shogo Misumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural basis of the hepatitis B virus X protein in complex with DDB1 2025 ·Proceedings of the National Academy of Sciences ·Hiroki Tanaka, (unknown), (unknown), Shunsuke Kita, (unknown), Hiroyuki Takeda, Naoki Kishimoto, Shunsuke Sasaki, Shogo Misumi, Masashi Mizokami, Christine Neuveut, Takashi Sumikama, Mikihiro Shibata, Katsumi Maenaka, Shinichi Machida	0
2	Fermented Royal Jelly Enriched With 10‐Hydroxydecanoic Acid and Its Potential for Enhancing Mucosal Immunity 2025 ·Food Science & Nutrition ·(unknown), (unknown), Kaori Konishi, (unknown), Nobuaki Okumura, Norihiro SHIGEMATSU, Shogo Misumi, Shinji Takenaka	3
3	Total Syntheses of Phorbol and 11 Tigliane Diterpenoids and Their Evaluation as HIV Latency-Reversing Agents 2024 ·Journal of the American Chemical Society ·(unknown), Masanori Nagatomo, Akira Hirose, (unknown), Naoki Kishimoto, Satoshi Miura, (unknown), (unknown), Shogo Misumi, Masayuki Inoue	12
4	Structural and virologic mechanism of the emergence of resistance to M ^pro inhibitors in SARS-CoV-2 2024 ·Proceedings of the National Academy of Sciences ·Shin-ichiro Hattori, Haydar Bulut, Hironori Hayashi, Naoki Kishimoto, Nobutoki Takamune, Kazuya Hasegawa, Yuri Furusawa, Seiya Yamayoshi, Kazutaka Murayama, Hirokazu Tamamura, Mi Li, Alexander Wlodawer, Yoshihiro Kawaoka, Shogo Misumi, Hiroaki Mitsuya	7
5	Synthesis and Biological Evaluation of Simplified Ansellone Analogues with Lipophilic Side Chains as HIV Latency‐Reversing Agents 2023 ·Chemistry - A European Journal ·(unknown), Naoki Kishimoto, (unknown), (unknown), Satoshi Miura, (unknown), (unknown), Jun‐ichi Haruta, Shogo Misumi, Mitsuhiro Arisawa, Kenichi Murai	1
6	Total Synthesis of Ansellone G and Phorbadione 2022 ·The Journal of Organic Chemistry ·(unknown), (unknown), Naoki Kishimoto, (unknown), Satoshi Miura, Shogo Misumi, Makoto Sako, Mitsuhiro Arisawa, Kenichi Murai	4
7	Isolation, Synthesis, and Structure–Activity Relationship Study on Daphnane and Tigliane Diterpenes as HIV Latency-Reversing Agents 2022 ·Journal of Medicinal Chemistry ·Ahmed H. El‐Desoky, Keisuke Eguchi, Naoki Kishimoto, (unknown), Hikaru Kato, Yuki Hitora, Shunsuke Kotani, Teruya Nakamura, Soken Tsuchiya, Teppei Kawahara, Masato Watanabe, Mikiyo Wada, Makoto Nakajima, Takashi Watanabe, Shogo Misumi, Sachiko Tsukamoto	19
8	Total Synthesis and Biological Evaluation of the Potent HIV Latency-Reversing Agent Ansellone A and its Analogues 2021 ·Organic Letters ·(unknown), Kenichi Murai, Naoki Kishimoto, (unknown), Shogo Misumi, Mitsuhiro Arisawa	12
9	Free radical scavenging, α-glucosidase inhibitory and lipase inhibitory activities of eighteen Sudanese medicinal plants 2018 ·BMC Complementary and Alternative Medicine ·(unknown), Hari Prasad Devkota, Mikiyo Wada, Naoki Kishimoto, (unknown), Tsuyoshi Shuto, Shogo Misumi, Hirofumi Kai, Takashi Watanabe	34
10	Virion-incorporated alpha-enolase suppresses the early stage of HIV-1 reverse transcription 2017 ·Biochemical and Biophysical Research Communications ·Naoki Kishimoto, (unknown), Kengo Yamamoto, Nobutoki Takamune, Shogo Misumi	14
11	The C -terminal domain of glyceraldehyde 3-phosphate dehydrogenase plays an important role in suppression of tRNA Lys3 packaging into human immunodeficiency virus type-1 particles 2016 ·Biochemistry and Biophysics Reports ·Naoki Kishimoto, (unknown), (unknown), Nobutoki Takamune, Shozo Shoji, Shogo Misumi	7
12	ATP generation in a host cell in early-phase infection is increased by upregulation of cytochrome c oxidase activity via the p2 peptide from human immunodeficiency virus type 1 Gag 2015 ·Retrovirology ·Minako Ogawa‐Tominaga, Yuki Takemoto, (unknown), Daisuke Inoue, Naoki Kishimoto, Nobutoki Takamune, Shozo Shoji, Shinya Suzu, Shogo Misumi	16
13	N -myristoyltransferase 1 enhances human immunodeficiency virus replication through regulation of viral RNA expression level 2015 ·Biochemical and Biophysical Research Communications ·(unknown), Nobutoki Takamune, Naoki Kishimoto, Shozo Shoji, Shogo Misumi	5
14	Effects of Immunization with CCR5-Based Cycloimmunogen on Simian/HIVSF162P3 Challenge 2006 ·The Journal of Immunology ·Shogo Misumi, Daisuke Nakayama, (unknown), (unknown), R Mukai, (unknown), Tadashi Nakasone, (unknown), Hideaki Shibata, (unknown), Nobutoki Takamune, Shozo Shoji	27
15	Zn ²⁺ Binding to Cysteine-Rich Domain of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein Is Associated with Tat Protein-Induced Apoptosis 2004 ·AIDS Research and Human Retroviruses ·Shogo Misumi, Nobutoki Takamune, (unknown), (unknown), Shozo Shoji	17
16	Blocking of Human Immunodeficiency Virus Type-1 Virion Autolysis by Autologous p2gag Peptide 2004 ·The Journal of Biochemistry ·Shogo Misumi	3
17	Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation 2002 ·Amyloid ·Katsuki Haraoka, Yukio Ando, Eiko Ando, Xuguo Sun, Masaaki Nakamura, Hisayasu Terazaki, Shogo Misumi, (unknown), (unknown), Shozo Shoji, Takashi Ishizaki, Hiroaki Okabe, Hidenobu Tanihara	30
18	Myristoylation of Human Immunodeficiency Virus Type 1 gag Protein Is Required for Efficient env Protein Transportation to the Surface of Cells 2001 ·Biochemical and Biophysical Research Communications ·(unknown), Shogo Misumi, (unknown), Ichiro Takahashi, Shozo Shoji	9
19	Evidence as a HIV-1 Self-Defense Vaccine of Cyclic Chimeric Dodecapeptide Warped from Undecapeptidyl Arch of Extracellular Loop 2 in Both CCR5 and CXCR4 2001 ·Biochemical and Biophysical Research Communications ·Shogo Misumi, Nobutoki Takamune, Yasuo Ido, Shinichiro Hayashi, (unknown), (unknown), (unknown), (unknown), Shozo Shoji	6
20	Down‐regulation of N‐myristoyl transferase expression in human T‐cell line CEM by human immunodeficiency virus type‐1 infection 2001 ·FEBS Letters ·Nobutoki Takamune, (unknown), Hiroki Takeuchi, Shogo Misumi, Shozo Shoji	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact